Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Late term tolerance in head neck cancer patients irradiated in the IMRT era.

Studer G, Linsenmeier C, Riesterer O, Najafi Y, Brown M, Yousefi B, Bredell M, Huber G, Schmid S, Studer S, Zwahlen R, Rordorf T, Glanzmann C.

Radiat Oncol. 2013 Nov 5;8:259. doi: 10.1186/1748-717X-8-259.

PMID:
24192223
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.

Studer G, Huguenin PU, Davis JB, Kunz G, Lütolf UM, Glanzmann C.

Radiat Oncol. 2006 Mar 31;1:7.

PMID:
16722599
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].

Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A.

Otolaryngol Pol. 2011 Sep;65(5 Suppl):117-25. Polish.

PMID:
22000261
[PubMed - indexed for MEDLINE]
4.

IMRT: preliminary results in a series of advanced head-and-neck cancer patients.

Vila Capel A, Vilar Palop J, Pedro Olivé A, Sanchez-Reyes Fernandez A, Vayreda Ribera J, Julià Sanahuja JC, Pérez de Olaguer Agustín J, Artola Codina N, Moya Cascant LM, Rubio Calatayud E, Carrera Domenech G.

Clin Transl Oncol. 2013 Mar;15(3):233-42. doi: 10.1007/s12094-012-0911-2. Epub 2012 Jul 27.

PMID:
22855193
[PubMed - indexed for MEDLINE]
5.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
[PubMed - indexed for MEDLINE]
6.

Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer.

Studer G, Rordorf T, Glanzmann C.

Radiat Oncol. 2011 Sep 22;6:120. doi: 10.1186/1748-717X-6-120.

PMID:
21936952
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).

Studer G, Studer SP, Zwahlen RA, Huguenin P, Grätz KW, Lütolf UM, Glanzmann C.

Strahlenther Onkol. 2006 May;182(5):283-8.

PMID:
16673062
[PubMed - indexed for MEDLINE]
8.

Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.

Villeneuve H, Després P, Fortin B, Filion E, Donath D, Soulières D, Guertin L, Ayad T, Christopoulos A, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1866-71. doi: 10.1016/j.ijrobp.2011.02.031. Epub 2011 Apr 15.

PMID:
21497452
[PubMed - indexed for MEDLINE]
9.

Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience.

Van Gestel D, Van Den Weyngaert D, Schrijvers D, Weyler J, Vermorken JB.

Br J Radiol. 2011 Apr;84(1000):367-74. doi: 10.1259/bjr/67058055.

PMID:
21415302
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.

Biagioli MC, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, Han HS, Markoe A.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1067-73.

PMID:
17967302
[PubMed - indexed for MEDLINE]
11.

Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.

McCloskey SA, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Sullivan M, Mashtare TL Jr, Khan MK, Loree TR, Singh AK.

Am J Clin Oncol. 2009 Dec;32(6):587-91. doi: 10.1097/COC.0b013e3181967dd0.

PMID:
19581794
[PubMed - indexed for MEDLINE]
12.
13.

Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.

Truong MT, Romesser PB, Qureshi MM, Kovalchuk N, Orlina L, Willins J.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):158-64. doi: 10.1016/j.ijrobp.2011.10.079. Epub 2012 Jan 31.

PMID:
22300574
[PubMed - indexed for MEDLINE]
14.

Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.

Maguire PD, Papagikos M, Hamann S, Neal C, Meyerson M, Hayes N, Ungaro P, Kotz K, Couch M, Pollock H, Tepper J.

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1081-8. doi: 10.1016/j.ijrobp.2009.12.046. Epub 2010 Apr 8.

PMID:
20378262
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.

Cvek J, Kubes J, Skacelikova E, Otahal B, Kominek P, Halamka M, Feltl D.

Strahlenther Onkol. 2012 Aug;188(8):666-70. doi: 10.1007/s00066-012-0128-x. Epub 2012 Jun 1.

PMID:
22648405
[PubMed - indexed for MEDLINE]
16.

Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT).

Peponi E, Glanzmann C, Willi B, Huber G, Studer G.

Radiat Oncol. 2011 Jan 5;6:1. doi: 10.1186/1748-717X-6-1.

PMID:
21208415
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
[PubMed - indexed for MEDLINE]
18.

Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.

Combs SE, Salehi-Allameh B, Habermehl D, Kessel KA, Welzel T, Debus J.

Head Neck. 2014 Jan;36(1):22-7. doi: 10.1002/hed.23274. Epub 2013 May 4.

PMID:
23649985
[PubMed - indexed for MEDLINE]
19.

Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.

Toledano I, Graff P, Serre A, Boisselier P, Bensadoun RJ, Ortholan C, Pommier P, Racadot S, Calais G, Alfonsi M, Favrel V, Giraud P, Lapeyre M.

Radiother Oncol. 2012 Apr;103(1):57-62. doi: 10.1016/j.radonc.2011.12.010. Epub 2012 Jan 31.

PMID:
22296746
[PubMed - indexed for MEDLINE]
20.

Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Lambrecht M, Nevens D, Nuyts S.

Strahlenther Onkol. 2013 Mar;189(3):223-9. doi: 10.1007/s00066-012-0289-7. Epub 2013 Jan 16.

PMID:
23319256
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk